Advertisement

Topics

Egalet Announces Filing of Supplemental New Drug Application for OXAYDO® to FDA

08:54 EST 1 Dec 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
WAYNE, Pa., Dec. 1, 2016 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, to...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Egalet Announces Filing of Supplemental New Drug Application for OXAYDO® to FDA"

Quick Search
Advertisement
 

Relevant Topics

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...